What is it about?
To the best of our knowledge, there are currently no published data on the historical and recent usage of continuous glucose monitoring (CGM) in diabetes clinical trials. We analyzed 2,032 clinical trials of 40 diabetes therapies currently on the market with a start date between January 1, 2000 and December 31, 2019, finding that 119 (5.9%) of these trials used CGM and that CGM use has increased over time.
Featured Image
Read the Original
This page is a summary of: Continuous Glucose Monitoring Use in Clinical Trials for On-Market Diabetes Drugs, Clinical Diabetes, April 2021, American Diabetes Association,
DOI: 10.2337/cd20-0049.
You can read the full text:
Contributors
The following have contributed to this page
